Introduction
Blood transfusion service (BTS) is an integral part of health care system which primarily aims at providing adequate and safe blood and blood components. For this, the most important step is proper selection of the blood donor by formulating and following donor selection criteria. Appropriate donor selection ensures safety of donor as well as recipient. Donors can donate whole blood or a particular component like platelets during apheresis procedure. Platelet transfusions are indicated in patients who are bleeding or at an increased risk of bleeding secondary to thrombocytopenia or platelet dysfunction. Platelets for transfusion can be provided as random donor platelets / platelet concentrate prepared by harvesting routine whole blood donation or as single donor platelets by apheresis. Plateletpheresis procedure is designed to collect large number of platelets from single donor thereby giving more consistent product. 1 As per guidelines of American association of blood banks plateletpheresis (Single Donor Platelets) unit must have platelet count of 3x 10 11 which in turn raises platelet count by 30,000-60,000 per microlitre and is equivalent to 4-6 units of random platelet concentrates 2 . Besides providing good yield, single donor platelets have numerous advantages over random donor platelets for the recipients which include decreased risk of transfusion transmitted infections, bacterial contamination and alloimmunization due to reduced donor exposure. 3 Over the years, the demand for single donor platelets has increased manifold. It is estimated that 79% of therapeutic platelet doses transfused in the United States of America are apheresis platelets 1 The demand of plateletpheresis is increasing in our country also mainly because of dengue epidemics since last 10-15 years. 4 Now a days, most of the tertiary care centers are demanding plateletpheresis to increase platelet count of patients. But prolonged procedure time, improper knowledge and social taboo are some of the factors that lead to noncooperation by donors in Indian scenario. Besides these, stringent donor selection criteria ofpredonation platelet count and hemoglobin concentration further diminish the donor pool. 3, 5 The present study was carried out to analyze the frequency and causes of donor deferral for plateletpheresis.
Materials and Methods
This retrospective study was carried out at SMS&R, Sharda Hospital, and Greater Noida over a period of one year (from 1 st Jan 2013 to 31 Dec 2013). Donor selection criteria for plateletpheresis followed at our institute were: a) Age 18-60 years b) Hb-12.5gm% c) Platelet count-1.5 lakhs d) Weight-55 Kg e) Good vein in one or both arms f) No Aspirin intake in last 72 hours g) ABO identical blood group h) Interval from last whole blood donation-3 months and 72 hours from last plateletpheresis i) Proper medical history j) Physical examination k) Negative serology for HIV, HBsAg, HCV, malaria parasite and syphilis Besides these, all other criteria for whole blood donation were followed. For ABO identical donors, detailed history and physical examination was done. This was followed by checking adequacy of vein and blood samples collection for complete blood counts and serological tests. Platelet counts were done on SYSMEX 1800i. The serological tests were done using ELISA for HIV, HBsAg (4th generation, Bio-Rad) and HCV (3rd generation, Bio-Rad). Test for Syphilis was done by RPR (Tulip Diagnostics). Test for malaria was done by Para bank (Tulip diagnostics). Donors who fulfilled above cited criteria were taken for apheresis by MCS Haemonetics, Intermittent flow cell separator.
Results
Over a period of one year 283 donors were screened for plateletpheresis, out of which 58 were deferred. Majority of donors deferred were males in 20 to 40 years age group. This can be because males of this age group constituted majority of donors screened. Reasons for donor deferral were divided into temporary and permanent. Out of 58, 52 (89.65%) were deferred for temporary reasons and 6 (10.35%) were deferred permanently-due to positive serology. Low platelet count was the most common cause of temporary deferral followed by low hemoglobin levels constituting 44.82% and 18.96% deferrals respectively. Two donors were deferred for dual reasons of low platelet and low hemoglobin levels. 
Discussion
Platelet transfusions are essential to prevent morbidity and mortality in patients who are severely thrombocytopenic and are at risk of spontaneous bleeding. The quality of single donor platelets (SDP) in terms of yield influences platelet recovery in the recipient and allows prolongation of intervals between transfusions .1 But the most significant limitation to ever increasing use of apheresis platelets is poor availability of SDP donors-in part due to increased procedure time, causing non cooperation by donors and partly due to lack of awareness. Besides these, ineligibility of donors due to low platelet count, low hemoglobin or low weight further aggravates the problem. In the present study, 20.5% platelet donors were deferred due to various reasons. A deferral rate of 10.6%-27.5% is described by other authors. 3, 5, 6, 7 In present study, most of the donor deferrals-89.65% were for temporary reasons. Low platelet count was most important cause accounting for 44.82% of deferrals followed by low hemoglobin contributing 18.96% of deferrals. This is comparable to Pujani et al who found 43.5% & 27 % of deferrals due to low platelet and low hemoglobin respectively 3 . Tondon et al and Pandey et al also observed the similar trends 6, 7 . But Kusumgar et al found 21 % and 29% deferrals due to low platelet count and low Hb respectively. 5 Two out of 58 donors were deferred for dual reasons i.e. low platelet and low hemoglobin. Out of 11 donors (18.96%) deferred for anemia, 6 (10.3%of total deferred) had Hb in range of 11.5-12.4 gm%. Kusumgar et al observed no effect on platelet yield or adverse donor reactions while performing apheresis in 49 donors with 11.5-12.4gm% hemoglobin and stated that one fifth of deferred donors can be reconsidered if criteria for hemoglobin is relaxed 5 . Fraser et al also found lowering the cut off value of hemoglobin up to 11.5 g/dl has no deleterious effect on apheresis donors. 8 This may be because only 20-40 ml of blood (PRBC) is lost if procedure is performed properly. The rationale for hemoglobin testing and setting the cut off at > 12.5g/dl for donor acceptance is justified in whole blood donation because of the red cell loss during donation with a decrease of 1g/dl in Hemoglobin level; but not in case of plateletpheresis. . Tondon et al found 22% decrease in platelet count after the procedure 6 . Literature has documented no adverse effect in donors even at a post platelet count of 69,000 10 . But pre procedure platelet count effects platelet yield, therefore we follow a policy to do platelet count even in first time donors. In case of emergency and unavailability of donors, this criterion can be relaxed to reduce family anxiety. In our study, we deferred 4 (6.89%) donors having weight less than 55 kg. M Pujani et al & Kusumgar et al followed a cut off value of 60 kg and 50 Kg and deferred 4.7% donors and 5% donors for low weight respectively. Good venous access is an important criterion for successful completion of the procedure. Four donors (6.89%) were deferred for abnormal total and differential counts which is comparable to Kusumgar et al who observed 5% deferral due to abnormal white cell counts. Four donors were deferred for cause of medications and h/o recent surgeries/transfusion. Six out of 58 (10.3% of donors deferred) were positive for TTI. In a study done at the same institute 3.4% whole blood donors were found positive in serology while 2.1% of total donors screened for plateletpheresis were positive 12 .
Conclusion
The demand of plateletpheresis is increasing. Selection of plateletpheresis donor follows the stringency of whole blood donation criteria along with certain additional criteria. This leads to high rate of donor deferral. Majority of deferrals are due to temporary causes like low hemoglobin, low platelet count and low weight. As it is difficult to convince donors for plateletpheresis, screening criteria should be revised and formulated separately from whole blood donation criteria. In view of present study, criteria for hemoglobin and donor weight can be relaxed to suit Indian scenario.
